LA
GSK icon

Lifeworks Advisors’s GSK GSK Stock Holding History

Lifeworks Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,260
Closed -$235K – 342
2026
Q1 		$235K Buy
4,260
+60
+1% +$3.25K 0.03% 276
2025
Q4 		$206K Buy
+4,200
New +$196K 0.03% 320
2025
Q2 		– Sell
-5,219
Closed -$202K – 320
2025
Q1 		$202K Buy
+5,219
New +$191K 0.03% 300

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Lifeworks Advisors's GSK Position: Q2 2026 in Review

Lifeworks Advisors sold out of GSK (GSK) in Q2 2026, closing a stake of 4,260 shares — an estimated $235K sold.

Lifeworks Advisors first reported a position in GSK in Q1 2025 and held it in 3 quarters. The position peaked at $235K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Lifeworks Advisors reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Lifeworks Advisors sold 4,260 GSK shares in Q2 2026, an estimated $235K.
  • Lifeworks Advisors first reported a position in GSK in Q1 2025 and held it in 3 quarters.
  • Lifeworks Advisors's GSK position peaked at $235K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Lifeworks Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.